|1.||Waters, David D: 14 articles (02/2015 - 09/2006)|
|2.||Breazna, Andrei: 12 articles (04/2015 - 06/2006)|
|3.||DeMicco, David A: 11 articles (04/2015 - 11/2008)|
|4.||LaRosa, John C: 10 articles (06/2013 - 09/2006)|
|5.||Kastelein, John J P: 10 articles (06/2013 - 09/2006)|
|6.||Jin, Jian-Ping: 9 articles (08/2012 - 07/2003)|
|7.||Seino, Yoshihiko: 8 articles (10/2013 - 04/2008)|
|8.||Mizuno, Kyoichi: 8 articles (10/2013 - 04/2008)|
|9.||Potter, James D: 8 articles (08/2006 - 03/2003)|
|10.||Fayyad, Rana: 6 articles (02/2015 - 08/2009)|
11/28/1994 - "A blinded prospective multicentre study representing 298 patients who on admission were suspected of acute myocardial infarction (AMI) to the coronary care units of six Scandinavian hospitals was undertaken to assess the diagnostic performance and prognostic efficacy of a new cardiospecific TnT immunoassay. "
11/01/1993 - "A blinded prospective multicentre study representing 298 patients suspected of having acute myocardial infarction (AMI), and admitted to the coronary care units of six Scandinavian Hospitals was undertaken to assess the diagnostic performance and prognostic efficacy of a new cardiospecific TnT immunoassay. "
07/15/2008 - "Working heart preparations were employed to study rat acute myocardial infarction and transgenic mouse hearts over-expressing the N-terminal truncated cardiac TnT (cTnT-ND). "
10/01/2001 - "The one-year risk of death in the noninvasive arm of the study increased by increasing levels of tnT (1.6% to 4.6%), whereas the risk of myocardial infarction showed an inverted U-shaped curve and was lower in the lowest (5.5%) and highest (8.4%) tnT groups than in the two intermediate groups (17.5% and 16.2%). "
01/01/2015 - "H-FABP can be used as an additional marker to hs-TnT in diagnosis of myocardial infarction (MI) and for exclusion of non-AMI (acute myocardial infarction) patients."
08/01/2005 - "Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER."
07/15/1994 - "The findings provide the first direct evidence of TnT and TnI shifts in an experimentally induced hypertrophied heart failure and has novel mechanistic implications for the future studies."
01/01/2014 - "Admission hs-TnT levels were associated with acute coronary artery occlusion, time to return of spontaneous circulation, heart failure, and renal function. "
12/15/2013 - "In middle-aged to older individuals, OSA severity is independently associated with higher levels of hs-TnT, suggesting that subclinical myocardial injury may play a role in the association between OSA and risk of heart failure. "
12/15/2013 - "Over a median of 12.4 (interquartile range, 11.6-13.1) years follow-up, hs-TnT was related to risk of death or incident heart failure in all OSA categories (P ≤ 0.05 in each category). "
|3.||Coronary Artery Disease (Coronary Atherosclerosis)
11/10/1998 - "The present study found the combination of baseline values of TnT, TnI, CK-MB mass, and ST-T changes in the ECG to be effective for early risk stratification in patients with unstable coronary artery disease."
03/01/2009 - "TNT was the first trial which showed that aggressive lipid lowering therapy was more protective than a moderate one in patients with stable coronary artery disease. "
10/01/2008 - "Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial."
11/15/2006 - "TnT demonstrated a mild correlation with recurrent infarct or angina at 12 months (OR 1.1, 95% CI 0.96 to 1.22, p <0.05) but appeared related to multivessel coronary artery disease (OR 1.47, 95% CI 1.05 to 1.99, p <0.01). "
05/01/2002 - "EDOB was positive in 22 of the 29 patients with coronary artery disease (76%) and TnT was raised in 14 of them (48%; p < 0.05).Conclusion. "
|4.||Chest Pain (Chest Pains)
08/01/2012 - "Sensitivity analysis showed a 25 % relative gain in predicting CCS using rule 3 compared to rule 1. Changes between two determinations of hs-TnT 6 h apart effectively improved specificity for CCS presence in high-risk chest pain patients. "
05/11/2010 - "Combined measurement of copeptin and TnT on admission improved the c-statistic from 0.84 for TnT alone to 0.93 in the overall population and from 0.77 to 0.9 in patients presenting within 3 h after chest pain onset (CPO) (p < 0.001). "
02/01/2004 - "The purpose of the present study was to determine the clinical utility, sensitivity and specificity of the combination of TnT levels and 2DE in patients presenting with chest pain, ST-depression, T-wave negative and no diagnostic ECG. "
01/01/2015 - "We investigated prospectively the prognostic value of admission samples of TnT, hsCRP, and BNP in 871 chest-pain patients from South-Western Norway and 982 patients from Northern Argentina, based on a similar protocol and database setup. "
01/01/2015 - "The specificity of H-FABP was higher compare to hs-TnT while sensitivity was comparable during 0-6 h of presentation of chest pain. "
02/01/2011 - "The Treating to New Targets (TNT) study has recently provided evidence that reduction in LDL-C levels below 2·6 mmol L⁻¹ lowers the risk of cerebrovascular events by an additional 20% to 25%, thereby confirming the value of statin therapy in preventing transient ischaemic attacks and stroke. "
04/01/2008 - "Most secondary prevention trials (4S, CARE, LIPID, HPS, GREACE and TNT) showed a beneficial effect of statins in stroke prevention. "
03/01/2008 - "Additionally, in the TNT trial, intensive lipid lowering provided further stroke risk reduction compared with moderate lipid lowering in patients with stable CAD. "
06/01/2006 - "The aims of the present study were to assess the prevalence of ECG and TnT changes in acute ischaemic stroke, to investigate whether ischaemic-like ECG changes correlate to a rise in TnT and to examine whether ECG changes and elevated TnT predict a poor short-time outcome. "
01/01/2012 - "Elevated levels of hsTnT are frequently present in patients with acute ischemic stroke previously tested normal with a fourth-generation TnT assay. "
|1.||Troponin T (T, Troponin)
|3.||Biological Markers (Surrogate Marker)
|5.||Brain Natriuretic Peptide (Natrecor)
|7.||MB Form Creatine Kinase
|9.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|1.||Induced Heart Arrest (Cardioplegia)
|3.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)
|5.||Renal Dialysis (Hemodialysis)